Why the study?
Selecting appropriate frailty assessment tools remains a challenge, motivating a comparison of the incremental prognostic value of three frailty assessment tools in hospitalized patients undergoing cardiac interventions.
Does preprocedural three-dimensional frailty assessment (SPMSQ, SPPB, handgrip strength) improve the prediction of all-cause mortality and major adverse cardiac events compared to a basic clinical model in hospitalized patients aged ≥60 undergoing cardiac interventions?
Cohort (n=320)
No
Does preprocedural three-dimensional frailty assessment (SPMSQ, SPPB, handgrip strength) improve the prediction of all-cause mortality and major adverse cardiac events compared to a basic clinical model in hospitalized patients aged ≥60 undergoing cardiac interventions?
Preprocedural frailty assessment using the Short Physical Performance Battery (SPPB) provides significant incremental prognostic value over traditional clinical risk factors for predicting long-term mortality and MACE in older adults undergoing cardiac interventions.
Answers are grounded in this paper and cite their sources.
May enhance preprocedural risk stratification in older cardiac patients; extends observational frailty data but leaves open prospective validation before practice change.
Introduction Selecting appropriate frailty assessment tools remains a challenge. This study compared the incremental prognostic value of three assessment tools in predicting adverse outcomes in patients admitted with different cardiac conditions. Methodology We conducted a prospective, single-center cohort study at King Abdulaziz Cardiac Center, King Abdulaziz Medical City for National Guard, Riyadh, Saudi Arabia, between 2015 and 2017, including patients aged ≥60. A comprehensive three-dimensional (3D) frailty assessment was performed for hospitalized cardiac patients: the short portable mental status questionnaire (SPMSQ), short physical performance battery (SPPB), and handgrip strength measurement as a preprocedural evaluation. We followed patients until April 2025 for different endpoints. The endpoints were all-cause mortality (ACM) and major adverse cardiac events (MACE) (heart failure hospitalization, reinfarction, or arrhythmia). Various predictive model metrics were used to assess the incremental prognostic value of each frailty assessment relative to the basic clinical model. SAS 9.0 was used to run statistical analyses and models. Results A total of 320 patients (mean age, 72.9 ± 6.6 years; 30.3% female) underwent a 3D frailty assessment prior to undergoing various cardiac interventions, including coronary or valve interventions through surgical or minimally invasive procedures. The prevalence of cardiovascular risk factors, hypertension, diabetes, and dyslipidemia was 79.1%, 73.8%, and 60.0%, respectively. The median values for the three frailty scores were 2 (1, 3) for SPMSQ, 22 (16, 28) for handgrip, and 8 (5, 11) for SPPB. During the follow-up period, 90 (28.1%) patients died. When assessing incremental prognostic value, the SPPB trend improved prediction of 1-year ACM (adjusted OR: 0.876, 95% CI: 0.77–1.00; P = 0.052; ΔC = 0.009), and 5-year ACM (adjusted OR: 0.890, 95% CI: 0.80–0.99; P = 0.028; ΔC = 0.008) beyond traditional clinical predictors. A similar enhancement was observed for 30-day MACE (adjusted OR: 0.863, 95% CI: 0.75–1.00; P = 0.044; ΔC = 0.022) and 1-year MACE (adjusted OR: 0.860, 95% CI: 0.77–0.96; P = 0.005; ΔC = 0.023). Conclusions The SPPB measures a high incremental prognostic value for predicting ACM and MACE. Further validation is needed to support integrating these approaches into routine practice.
No takes yet. Share an insight, caveat, or question.
Ghazal et al. (2026) conducted a cohort in Hospitalized patients undergoing cardiac interventions (coronary or valve interventions) (n=320). Three-dimensional frailty assessment (SPPB, SPMSQ, and handgrip strength) vs. Basic clinical model was evaluated on All-cause mortality (ACM) and major adverse cardiac events (MACE: heart failure hospitalization, reinfarction, or arrhythmia) (OR 0.890, 95% CI 0.80-0.99, p=0.028).
Synapse has enriched 10 related papers. Consider them for comparative context: